Section Review: Anti-infectives: Penems: new oral β-lactam drugs

References

• WOODWARD RB: Recent advances in the chemistry of13-lactam antibiotics. In: Recent advances in the chemistry of13-lactam antibiotics. Elks J (Ed.). The Chemical Society, London (1977) Special Publication No. 23:167–180.
   Google Scholar
• ALFONSO A, GANGULY AK, GIRIJAVALLABHAN V,McCOMBIE S: Synthesis of penem antibiotics. In: Recent Advances in the cbemis of P-lactam antibiotics. Brown AG, Roberts SM (Eds.). The Royal Soc. Chem. (1984):266–279.
   Google Scholar
• KAWAMOTO I, ENDO R, SUGAWARA S: Synthesis andantimicrobial activity of a new penem, sodium (5R,65)-2-(2-11uoroethylthio)-641R)-l-hydroxyethyl]penem-3 -carboxylate.
   Google Scholar
• NISHI T, HIGASHI K, SOGA T, TAKEMURA M, SATO M:Synthesis and antibacterial activity of new 2-substituted penem II. J. Antibiotics (1993) 47:357–369.
   Web of Science ®Google Scholar
• KIM CU, MISCO PF, LUH BY, HITCHCOCK JM: Synthesis and in vitro activity of C-2 quarternary heterocydic alkylthiocarbapenems. J. Antibiotics (1987) 40:1707–1715.
   PubMedGoogle Scholar
• SUNAGAWA M:H, MATSUMURA H, INOUE T, FUKASAWA M: New penem compounds with 5'-substituted pyrrolid-inylthio group at a C-2 side chain. Comparision of their biological properties with those of carbapenem com-pounds. J. Antibiotics (1992) 45:500–504.
   Google Scholar
• NISHI T, HIGASHI K, TAKEMURA M, SATO M: Synthesisand antibacterial activity of new 2-substituted penems 1.1 Antibiotics (1993) 46:1740–1751.
   PubMed Web of Science ®Google Scholar
• BEDESCHI A, VISENTIN G, PERRONE E, GIUDICI F, ZARINIF, FRANCESCHI G, MEINARDI G, CASTELLANI P, JABES D, ROSSI R, DELLA BRUNA C: Synthesis and structure-activ-ity relations in the class of 2-(pyridyl) penems. J. Anti-biotics (1990) 43:306–313.
   PubMed Web of Science ®Google Scholar
• PERRONE E, ALPEGIANI M, BEDESCHI A, GIUDICI F,ZARINI F, FRANCESCHI G, DELLA BRUNA C, JABES D, MEINARDI G: Novel quaternary ammonium penems: the [(pyridinio)methyl]-phenyl derivatives. J. Antibiotics (1987) 40:1636–1639.
   PubMed Web of Science ®Google Scholar
• COOKE MB, MOORE KW, ROSS BC, TURNER SE: Synthesisand some antibacterial properties of 2-oxypenems. In: Recent Advances in the chemistry of 13-lactam antibiotics Brow AG, Roberts SM (Eds.). The Royal Soc. Chem. (1984):100–115.
   Google Scholar
• SEIBERT G, ISERT D, KLESEL N, LIMBERT M, PRIES A,SCHR1NNER E, COOKE M, WALMSLEY J, BENTLEY PH: BRE 664, A new parenteral peneta L Antibacterial activity in vitro. J. Antibiotics (1987) 40:660–667.
   PubMedGoogle Scholar
• ISHIGURO M, IWATA H, NAKATSUKA T, TANAKA R, MAEDA Y, NISHIHARA T, NOGUCHI T, NISHINO T: Syn-thesis and in vitro activity of novel 2-chiral substituted penems. J. Antibiotics (1988) 41:1685–1693.
   PubMed Web of Science ®Google Scholar
• ALTAMURA M, GIANNOTTI D, PERROTTA E, SBRACI P, PESTELLENI V, ARCAMONE M: Synthesis of new penem dithiocarbatnates. Bioorg. Med. Chem. Letters (1993) 3 :2159–2164.
   Web of Science ®Google Scholar
• GIRIJAVALLABHAN V, GANGULY AK, LIU Y-T, PINTO PA, PATEL N, HARE RH, MILLER GH: A new class of penems - C-2-N-substituted compounds - synthesis and antibac-terial activily J. Antibiotics (1986) 39:1187–1190.
   PubMed Web of Science ®Google Scholar
• HORI S, SHIMIDA J, HIAROTSU I, INOMATA N, HAYASHI Y, NISHIMURA M, OHNO T, ISHIHARA T: Lesser epilepto-genic activity of SY 5555, a novel penem antibiotic. 32nd Intersci. Conf. Antimicrob. Agent Chemother. Anaheim, 1992. Abstract 393.
   Google Scholar
• SCHLIAMSER SE, BROHOLM K-A, LILJEDAHL A-L, NORBY RS: Comparative neurotoxicity of benzylpenieillin, imipenem/cilastatin and FCE 22101, a new injectable penem. j Antimicrob. Chemother. (1988) 22:687–695.
   PubMed Web of Science ®Google Scholar
• PERRONE E: Penems: conception and evolution of a new class of 13-lactam antibiotics. II Farmaco (1988) Suppl 12:1075–1095.
   Google Scholar
• SPANGLER SK, JACOBS MR, APPELBAUM PC: In vitro susceptibility of 185 penicillin-susceptible and -resis-tant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixirne, ce-faclor, cefpodoxime, cefuroxime, and cefdinir. Antimi-crob. Agents. Chemother. (1994) 38:2902–2904.
   PubMed Web of Science ®Google Scholar
• NISHINO T, SPANGLER SK, JACOBS MR, APPELBAUM PC:Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clin-damycin, and metronidazole against 384 anaerobic bacteria. Antimicrob. Agents Chemother. (1994) 38:2599–2604.
   PubMed Web of Science ®Google Scholar
• ALTAMURA M, PEROTTA E, SBRACI P, PESTELLINI V, AR-RAMONE F: Synthesis and antibacterial activity of MEN 1070, a new penern antibiotic. Bio-org. Med. Chem. Lett. (1995) 5:555–558.
   Web of Science ®Google Scholar
• CORMICAN MG, JONES RN: Evaluation of the in vitroactivity of faropenem (SY 5555/SUN 5555) against res-piratory tract pathogens and 13-lactamase producing bacteria. J. Antimicrob. Chemother. (1995) 35:535–539.
   PubMed Web of Science ®Google Scholar
• NISHONO T, OKAMOTO K, IWAO K, OTSUKI M: In vitro and in vivo antibacterial activities of SY 5555, a novel oral penem antibiotic. Chemotherapy (Tokyo) (1994) 42\(Suppl. 1):51–71.
   Google Scholar
• DELLA BRUNA C, MEINARDI G: Relationship between Inhibition zone size and MIC of the penem FCE 22101 on clinically relevant pathogens. In: Progress in Antimi-crobial and Anticancer Chemotherapy, Berkoda B (Ed.). Ecomed, Istanbul (1987):312–314.
   Google Scholar
• FUCHS PC, BARRY AL, SEWELL DL: Antibacterial activityof WY-49605 (SUN 5555) and six other oral agents and selection of disk content. 34th Intersci. Conf. Antimicrob. Agents Chemother. Orlando, 1994.
   Google Scholar
• GOOTZ T, GIRARD D, SCHELKLEY W, TENSFELDT T, FOULDS G, KELLOGG M, CAMPBELL BJASYS J, KELBAUGH P, VOLKMANN R, HAMANAKA E: Pharmacokinetic stud-ies in animals of a new parenteral penem CP-65207 and its oral prodrug ester J. Antibiotics (1990) 43:422–432.
   PubMed Web of Science ®Google Scholar
• NAKASHIMA M, UMEMURA K: Pharnaacokinetks of SUN208 in healthy male volunteers. 35th Intersci. Conf. An-timicrob. Agents Chemother, San Francisco, 1995.
   Google Scholar
• EDWARDS DMF, PELLIZZONI C, STROLIN BM, BIZIEN A,MOLINARI M, LEBEAUT A, SASSELLA D: FCE 22891, Phar-macokinetics in the elderly. 6th Eur. Cong. Microbiol. Infect. Dis. Sevilla, 1993.
   Google Scholar
• FOULDS G, KNIRSCH AK, LAZAR JD, TENSFELDT TG, GERBER N: Pharmacokinetics of the penem CP-65207 and its separate stereoisomers in humans. Antimicrob. Agents Chemother. (1991) 35:665–671.
   PubMed Web of Science ®Google Scholar
• FRANCESCHI G, FOGLIO M, ALPEGIANI M, BATTISTINI C,BEDESCHI A, PERRONE E, ZARINI F, ARCAMONE F: Syn-thesis and biological properties of sodium (5R,6S, 8R)-6-a-hydrox-yethyl- 2 -carbamoyloxy - methyl - 2 - penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.1 Antibiotics (1983) 36:938–941.
   Google Scholar
• FUJII R, NISHIMURA T: Phartnacokinetic and clinicalstudies of fropenem dry syrup in the pediatric field. 9th Mediter. Cong. Chemother. Milano, 1994.
   Google Scholar
• GOOTZ T, RETSMA J, GERARD A, HAMANA1CA E, ANDER-SON M, SOKOLOWSKI S: In vitro activity of CP-65207, a new penem antimicrobial agent, in comparision with those of other agents. Antimicrob. Agents Chemother. (1989) 33:1160–1166.
   PubMedGoogle Scholar
• INOUE E, MITSUHASHI M: In vitro antibacterial activityand 13-lactamase stability of SY-5555, a new oral penem antibiotic. Antimicrob. Agents Chemotber. (1994) 38:1974–1979.
   PubMed Web of Science ®Google Scholar
• LODE H, SAATHOFF A, HAMPEL B, DEPPERMANN KM, BORNER K, KOEPPE P, RAU M, CARELLA G: Pharmacoki-netics of FCE 22891, a new oral penem. 28th Intersci. Conf. Antimicrob. Agent Chemother. Los Angeles, 1988. Ab-stract 160.
   Google Scholar
• MITSUHASHI M, FRANCESHI G: Penem antibiotics. Japan Sc. Soc. Press & Springer Verlag (1991):130.
   Google Scholar
• NAKASHIMA M: Pharmacoltinetics and safety investiga-tion of fropenem in healthy male volunteers. 9th Mediter. Cong. Chemother. Milano, 1994.
   Google Scholar
• NISHINO T, MAEDA Y, OHTSU E, KOLZUKA S, ET AL.: Studies on penem antibiotics II. In vitro activity of SUN 5555, a new oral penem. J. Antibiotics (1989) 42:977–988
   Google Scholar
• OKONOGI K, MARI T, KAKAO M, NOJI Y: Antibacterialactivities of a new oral penem„ 1'MA-230, and its active form, AMA-3176. 33rd Intersci. Conf. Antimicrob. Agents Chemother. New Orleans, 1993. Abstract 927.
   Google Scholar
• PERRONE E, ALPEGIANI M, BEDESCHI A, GIUDICI F, ZARINI F, FRANCESCHI G: 2-(quaternary ammonio)-methyl penems. J. Antibiotics (1986) 36:1351–1355.
   Google Scholar
• PHILLIPS I, WISE R, NEU HC: An oral penem antibioticSch 29482.1 Antimicrob. Chemother. (1982) 9(Suppl. C).
   Google Scholar
• REEVES D, SPELLER D, SPENCER R, DALY PJ: FCE 22101, anew penem antibacterial, and its oral prodrug FCE 22891.J. Antimicrob. Chemother. (1989) 23(Suppl. C).
   Google Scholar
• TAKAMOTO M, ISHIBASHI T: Pharmacoldnetic profile offropenem in elderly patients with respiratory infec-tions. 9th Mediter, Cong. Chemother. Milano, (1994).
   Google Scholar
• WISER, PHILLIPS I: Sch 34343- anew parenteral penem. I Antimicrob. Chemother. (1985) 15(Suppl. C).
   Google Scholar
• WISE R, ANDRE/CS JM, PIDDOCK LJV: In vitro activity of CGP 31608, a new penem. Antimicrob. Agents Chemother. (1987) 31:267–273.
   PubMed Web of Science ®Google Scholar